生存率-话题@MedSci

#生存率#

482篇内容 | 3255人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1256904, encodeId=6fae12569048d, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Radiology：利用胸片的深度学习模型预测COPD患者生存率优于FEV1, objectType=article, longId=729127, objectId=42dbe29127f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42dbe29127f3, replyNumber=0, likeNumber=52, createdTime=2022-06-12, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42dbe29127f3, moduleTitle=Radiology：利用胸片的深度学习模型预测COPD患者生存率优于FEV1, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42dbe29127f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256903, encodeId=9f861256903ce, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=ASCO 2022 | 慢性淋巴细胞白血病一线疗法：Calquence联合奥妥珠单抗持续生存获益：5年生存率达到90%！, objectType=article, longId=728833, objectId=026ae2883362, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=026ae2883362, replyNumber=0, likeNumber=55, createdTime=2022-06-09, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=026ae2883362, moduleTitle=ASCO 2022 | 慢性淋巴细胞白血病一线疗法：Calquence联合奥妥珠单抗持续生存获益：5年生存率达到90%！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=026ae2883362)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256902, encodeId=5dc11256902f4, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=ASCO：转移性胰腺癌患者化疗免疫治疗后生物特征与生存率的关系, objectType=article, longId=728269, objectId=0f7ce282691b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f7ce282691b, replyNumber=0, likeNumber=49, createdTime=2022-06-01, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f7ce282691b, moduleTitle=ASCO：转移性胰腺癌患者化疗免疫治疗后生物特征与生存率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f7ce282691b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256901, encodeId=70271256901bb, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=2022 ASCO：免疫治疗时代，原发灶不明的恶性黑色素瘤患者生存率得到改善, objectType=article, longId=728231, objectId=69a9e28231d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69a9e28231d1, replyNumber=0, likeNumber=54, createdTime=2022-06-01, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69a9e28231d1, moduleTitle=2022 ASCO：免疫治疗时代，原发灶不明的恶性黑色素瘤患者生存率得到改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69a9e28231d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256900, encodeId=e419125690009, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA:二甲双胍对非糖尿病乳腺癌患者侵袭性疾病生存率的影响, objectType=article, longId=727994, objectId=6942e279944e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6942e279944e, replyNumber=0, likeNumber=47, createdTime=2022-05-29, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6942e279944e, moduleTitle=JAMA:二甲双胍对非糖尿病乳腺癌患者侵袭性疾病生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6942e279944e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256898, encodeId=ae001256898a5, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Eur Urol Focus：基线健康相关生活质量可预测根治性膀胱切除术后的膀胱癌特异性生存率, objectType=article, longId=726589, objectId=410de265896f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=410de265896f, replyNumber=0, likeNumber=53, createdTime=2022-05-12, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=410de265896f, moduleTitle=Eur Urol Focus：基线健康相关生活质量可预测根治性膀胱切除术后的膀胱癌特异性生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=410de265896f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256897, encodeId=0f53125689e97, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA Cardiol：院外心脏骤停患者的10年生存率, objectType=article, longId=726358, objectId=dad3e26358ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dad3e26358ad, replyNumber=0, likeNumber=45, createdTime=2022-05-09, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dad3e26358ad, moduleTitle=JAMA Cardiol：院外心脏骤停患者的10年生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dad3e26358ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256899, encodeId=75871256899b2, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA Cardiol：急性心肌梗死患者的10年生存率, objectType=article, longId=726356, objectId=5c25e2635677, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c25e2635677, replyNumber=0, likeNumber=43, createdTime=2022-05-09, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c25e2635677, moduleTitle=JAMA Cardiol：急性心肌梗死患者的10年生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c25e2635677)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256896, encodeId=1c401256896ba, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Cancer Discovery：余棣华团队发现，维生素E能够提高癌症患者生存率，通过激活树突状细胞，增强癌症免疫治疗效果, objectType=article, longId=724442, objectId=6310e24442f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6310e24442f9, replyNumber=0, likeNumber=38, createdTime=2022-04-18, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6310e24442f9, moduleTitle=Cancer Discovery：余棣华团队发现，维生素E能够提高癌症患者生存率，通过激活树突状细胞，增强癌症免疫治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6310e24442f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256895, encodeId=b0ed1256895e2, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Stroke：急性卒中后的长期生存率、卒中复发和预期寿命, objectType=article, longId=724357, objectId=fc10e2435740, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc10e2435740, replyNumber=0, likeNumber=49, createdTime=2022-04-17, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc10e2435740, moduleTitle=Stroke：急性卒中后的长期生存率、卒中复发和预期寿命, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc10e2435740)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256894, encodeId=4c1912568946d, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=AACR 2022：Sotorasib在KRAS G12C+ NSCLC的2年生存率上表现惊人, objectType=article, longId=724154, objectId=839ce2415432, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=839ce2415432, replyNumber=0, likeNumber=40, createdTime=2022-04-14, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=839ce2415432, moduleTitle=AACR 2022：Sotorasib在KRAS G12C+ NSCLC的2年生存率上表现惊人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=839ce2415432)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256893, encodeId=e58c1256893bd, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=AJH：急性髓性白血病强化化疗的生存率预测及其特征关联, objectType=article, longId=723823, objectId=9ce9e23823e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ce9e23823e7, replyNumber=0, likeNumber=46, createdTime=2022-04-10, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ce9e23823e7, moduleTitle=AJH：急性髓性白血病强化化疗的生存率预测及其特征关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ce9e23823e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256892, encodeId=c6bc125689297, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Cancers：我们对0 - 10岁尤文肉瘤骨骼发育不全儿童的生存率了解多少？, objectType=article, longId=723654, objectId=bc1ae236549d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc1ae236549d, replyNumber=0, likeNumber=43, createdTime=2022-04-08, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc1ae236549d, moduleTitle=Cancers：我们对0 - 10岁尤文肉瘤骨骼发育不全儿童的生存率了解多少？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc1ae236549d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256891, encodeId=523b125689116, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=接种疫苗保护力或高于被感染，阿司匹林可提高重症患者生存率丨新冠研究一周进展, objectType=article, longId=301778, objectId=8f59301e788d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f59301e788d, replyNumber=0, likeNumber=43, createdTime=2022-03-29, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f59301e788d, moduleTitle=接种疫苗保护力或高于被感染，阿司匹林可提高重症患者生存率丨新冠研究一周进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f59301e788d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256887, encodeId=674a125688e4f, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=NEJM：达洛鲁胺对转移性激素敏感性前列腺癌生存率的影响, objectType=article, longId=301583, objectId=f6873015839b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6873015839b, replyNumber=0, likeNumber=42, createdTime=2022-03-26, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6873015839b, moduleTitle=NEJM：达洛鲁胺对转移性激素敏感性前列腺癌生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6873015839b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256886, encodeId=dc7512568861c, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=NEJM：出生后2周开始氢化可的松治疗对改善早产儿无中重度支气管肺发育不良生存率效果不显著, objectType=article, longId=301582, objectId=108c3015822d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=108c3015822d, replyNumber=0, likeNumber=42, createdTime=2022-03-26, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=108c3015822d, moduleTitle=NEJM：出生后2周开始氢化可的松治疗对改善早产儿无中重度支气管肺发育不良生存率效果不显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=108c3015822d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256890, encodeId=63fc125689097, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=NEJM：氢化可的松可提高无支气管肺发育不良患者的生存率, objectType=article, longId=301580, objectId=d161301580b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d161301580b2, replyNumber=0, likeNumber=48, createdTime=2022-03-26, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d161301580b2, moduleTitle=NEJM：氢化可的松可提高无支气管肺发育不良患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d161301580b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256889, encodeId=b13f125688999, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA：临床试验证实，阿司匹林可改善新冠重症患者生存率, objectType=article, longId=301540, objectId=eba7301540f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eba7301540f3, replyNumber=0, likeNumber=48, createdTime=2022-03-25, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eba7301540f3, moduleTitle=JAMA：临床试验证实，阿司匹林可改善新冠重症患者生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eba7301540f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256888, encodeId=991112568883c, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J INTERN MED：乙酰水杨酸与细菌性肺炎球菌性肺炎患者生存率有关, objectType=article, longId=301501, objectId=949930150182, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=949930150182, replyNumber=0, likeNumber=52, createdTime=2022-03-25, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=949930150182, moduleTitle=J INTERN MED：乙酰水杨酸与细菌性肺炎球菌性肺炎患者生存率有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=949930150182)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256885, encodeId=5b8b12568859c, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=HAEMATOLOGICA：利妥昔单抗联合基于 LMB 的化疗方案治疗儿童和青少年原发性纵隔大 B 细胞淋巴瘤取得出色的生存率 , objectType=article, longId=300877, objectId=34583008e7c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34583008e7c5, replyNumber=0, likeNumber=52, createdTime=2022-03-17, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34583008e7c5, moduleTitle=HAEMATOLOGICA：利妥昔单抗联合基于 LMB 的化疗方案治疗儿童和青少年原发性纵隔大 B 细胞淋巴瘤取得出色的生存率 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34583008e7c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存率

2020-05-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Radiology：利用胸片的深度学习模型预测COPD患者生存率优于FEV1

2022-06-12

guoyibin (审核中...)

前往app查看评论内容

#生存率#

ASCO 2022 | 慢性淋巴细胞白血病一线疗法：Calquence联合奥妥珠单抗持续生存获益：5年生存率达到90%！

2022-06-09

guoyibin (审核中...)

前往app查看评论内容

#生存率#

ASCO：转移性胰腺癌患者化疗免疫治疗后生物特征与生存率的关系

2022-06-01

guoyibin (审核中...)

前往app查看评论内容

#生存率#

2022 ASCO：免疫治疗时代，原发灶不明的恶性黑色素瘤患者生存率得到改善

2022-06-01

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA:二甲双胍对非糖尿病乳腺癌患者侵袭性疾病生存率的影响

2022-05-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Eur Urol Focus：基线健康相关生活质量可预测根治性膀胱切除术后的膀胱癌特异性生存率

2022-05-12

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA Cardiol：院外心脏骤停患者的10年生存率

2022-05-09

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA Cardiol：急性心肌梗死患者的10年生存率

2022-05-09

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Cancer Discovery：余棣华团队发现，维生素E能够提高癌症患者生存率，通过激活树突状细胞，增强癌症免疫治疗效果

2022-04-18

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Stroke：急性卒中后的长期生存率、卒中复发和预期寿命

2022-04-17

guoyibin (审核中...)

前往app查看评论内容

#生存率#

AACR 2022：Sotorasib在KRAS G12C+ NSCLC的2年生存率上表现惊人

2022-04-14

guoyibin (审核中...)

前往app查看评论内容

#生存率#

AJH：急性髓性白血病强化化疗的生存率预测及其特征关联

2022-04-10

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Cancers：我们对0 - 10岁尤文肉瘤骨骼发育不全儿童的生存率了解多少？

2022-04-08

guoyibin (审核中...)

前往app查看评论内容

#生存率#

接种疫苗保护力或高于被感染，阿司匹林可提高重症患者生存率丨新冠研究一周进展

2022-03-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

NEJM：达洛鲁胺对转移性激素敏感性前列腺癌生存率的影响

2022-03-26

guoyibin (审核中...)

前往app查看评论内容

#生存率#

NEJM：出生后2周开始氢化可的松治疗对改善早产儿无中重度支气管肺发育不良生存率效果不显著

2022-03-26

guoyibin (审核中...)

前往app查看评论内容

#生存率#

NEJM：氢化可的松可提高无支气管肺发育不良患者的生存率

2022-03-26

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA：临床试验证实，阿司匹林可改善新冠重症患者生存率

2022-03-25

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J INTERN MED：乙酰水杨酸与细菌性肺炎球菌性肺炎患者生存率有关

2022-03-25

guoyibin (审核中...)

前往app查看评论内容

#生存率#

HAEMATOLOGICA：利妥昔单抗联合基于 LMB 的化疗方案治疗儿童和青少年原发性纵隔大 B 细胞淋巴瘤取得出色的生存率

2022-03-17

科室
- - 订阅+
  - 更多科室
工具
服务